Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Alzheimer’s Disease: Current Treatments and Potential New Agents
Current research focuses on agents that target secretase enzymes to prevent plaque accumulation.
Peripheral Arterial Disease From a Community Pharmacy Perspective
Peripheral arterial disease (PAD) describes a phenomenon in which circulation to the leg is diminished due to atherosclerosis, resulting in reduced blood flow and often causing pain that can be limiting to those who experience it.
OTC Transdermal Analgesic Patches in Pain Management
While these products are generally safe when used according to labeling, pharmacists must be familiar with available evidence in order to help patients safely self-medicate.
Opioids Often Overprescribed for Elbow Fractures in Children
Opioid-related research developments of interest to pharmacists.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.